|
51 |
Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients
Enthalten in Blood cancer journal Bd. 14, 2.5.2024, Nr. 1, date:12.2024: 1-8
|
|
|
|
52 |
Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia
Enthalten in Bone marrow transplantation Bd. 57, 7.10.2022, Nr. 12, date:12.2022: 1854
|
|
|
|
53 |
Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation
Enthalten in Leukemia Bd. 35, 14.4.2020, Nr. 1, date:1.2021: 215-224
|
|
|
|
54 |
Diagnostik und Therapie CAR-T-Zell-spezifischer Toxizitäten
Enthalten in Im Focus Onkologie Bd. 23, 30.10.2020, Nr. 5, date:10.2020: 32-37
|
|
|
|
55 |
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study
Enthalten in Annals of hematology Bd. 102, 25.1.2023, Nr. 3, date:3.2023: 547-561
|
|
|
|
56 |
Factors affecting pretransplant muscle strength in allogeneic stem cell transplant candidates prior transplantation
Enthalten in Supportive care in cancer Bd. 33, 10.1.2025, Nr. 2, date:2.2025: 1-12
|
|
|
|
57 |
First third-generation CAR T cell application targeting CD19 for the treatment of systemic IgM AL amyloidosis with underlying marginal zone lymphoma
Enthalten in Biomarker Research Bd. 11, 14.10.2023, Nr. 1, date:12.2023: 1-5
|
|
|
|
58 |
Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years
Enthalten in Blood cancer journal Bd. 14, 5.7.2024, Nr. 1, date:12.2024: 1-13
|
|
|
|
59 |
Hereditary thrombocythemia caused by a thrombopoietin (THPO) gain-of-function mutation associated with multiple myeloma and congenital limb defects
Enthalten in Annals of hematology Bd. 91, 28.3.2012, Nr. 7, date:7.2012: 1129-1133
|
|
|
|
60 |
High leukemia-free survival after TBI-based conditioning and mycophenolate mofetil-containing immunosuppression in patients allografted for chronic myelomonocytic leukemia: a single-center experience
Enthalten in Annals of hematology Bd. 99, 8.2.2020, Nr. 4, date:4.2020: 855-866
|
|
Administration
